Regulation of angiogenesis in the endometrium

Trends in Endocrinology and Metabolism

Volumn 12, Issue 4, 2001, Pages 147-151

  Smith, Stephen K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HOMEOSTASIS; HUMAN; MENSTRUAL CYCLE; PHYSIOLOGY; PREGNANCY; REVIEW; UTERUS BLEEDING; VASCULARIZATION;

ENDOMETRIOSIS; ENDOMETRIUM; ENDOTHELIAL GROWTH FACTORS; FEMALE; HOMEOSTASIS; HUMANS; LYMPHOKINES; MENSTRUAL CYCLE; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; UTERINE HEMORRHAGE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035345030     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(01)00379-4     Document Type: Review

References (62)

1. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364
2. Koch, A.E. (1998) Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 41, 951-962
3. Stehouwer, C.D.A. et al. (1997) Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc. Res. 34, 55-68
4. Sueishi, K. et al. (1997) Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor. Ann. New York Acad. Sci. 811, 311-324
5. Griffioen, A.W. and Molema, G. (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation, Pharmacol. Rev. 52, 237-268
6. Jaffe, R.B. (2000) Importance of angiogenesis in reproductive physiology. Semin. Perinatol. 24, 79-81
7. Smith, S.K. (1998) Angiogenesis, vascular endothelial growth factor and the endometrium. Hum. Reprod. Update 4, 509-519
8. Ludwig, H. et al. (1976) The re-epitheliazation of endometrium after menstrual desquamation. Arch. Gynekol. 221, 51-60
9. Ludwig, H. and Metzger, H. (1976) The Human Female Reproductive Tract: A Scanning Electron Microscopic Atlas, Springer-Verlag
10. Smith, S.K. The menstrual cycle. In The Endometrium (Aplin, J. et al., eds), Harwood Academic Publishers (in press)
11. King, A. et al. (1998) Human uterine lymphocytes. Hum. Reprod Update 4, 480-485
12. Rogers, P.A.W. (1996) Structure and function of endometrial blood vessels. Hum. Reprod. Update 2, 57-62
13. Abberton, K.M. et al. (1999) Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles. Hum. Reprod. 14, 3095-3100
14. Kohnen, G. et al. (2000) Spatially regulated differentiation of endometrial vascular smooth muscle cells. Hum. Reprod. 15, 284-292
15. Rogers, P.A. et al. (1998) Endometrial microvascular growth in normal and dysfunctional states. Hum. Reprod. Update 4, 503-508
16. Goodger, A.M. and Rogers, P.A.W. (1994) Endometrial endothelial cell proliferation during the menstrual cycle. Hum. Reprod. 9, 399-405
17. Abberton, K.M. et al. (1999) Vascular smooth muscle cell proliferation in arterioles of the human endometrium. Hum. Reprod. 14, 1072-1079
18. Benjamin, L.E. et al. (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591-1598
19. Ferrara, N. and Davis-Smyth, T (1997) The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25
20. Tischer, E. et al. (1991) The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954
21. Charnock-Jones, D.S. et al. (1993) Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod. 48, 1120-1128
22. Shifren, J.L. et al. (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab. 81, 3112-3118
23. Torry, D.S. et al. (1996) Vascular endothelial growth factor expression in cycling human endometrium. Fertil. Steril. 66, 72-80
24. Hornung, D. et al. (1998) Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil. Steril. 69, 909-915
25. Hyder, S.M. et al. (2000) Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res. 60, 3183-3190
26. Sharkey, A.M. et al. (2000) Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J. Clin. Endocrinol. Metab. 85, 402-409
27. Maltepe, E. et al. (1997) Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407
28. Claffey, K.P. et al. (1998) Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell 9, 469-481
29. Charnock-Jones, D.S. et al. (1999) Localisation of sites of expression of the angiogenic growth factors VEGF-B, VEGF-C and P1GF in human endometrium throughout the menstrual cycle. J. Soc. Gynecol. Invest. 6 (Suppl.), 150A
30. Croy, B.A. et al. (2000) Can murineuterine natural killer cells give insights into the pathogenesis of preeclampsia? J. Soc. Gynecol. Invest. 7, 12-20
31. Ashkar, A.A. and Croy, B.A. (1999) Interferon-gamma contributes to the normalcy of murine pregnancy. Biol. Reprod. 61, 493-502
32. Huang, S. et al. (1993) Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742-1745
33. Taki, S. et al. (1997) Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6, 673-679
34. Meduri, G. et al. (2000) Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle. Biol. Reprod. 62, 439-447
35. Joukov, V et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290-298
36. Maisonpierre, P.C. et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60
37. Suri, C. et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180
38. Li, X-F et al. Angiogenic growth factor mRNAs in uterine natural killer cells. J. Clin. Endocrinol. Metab. (in press)
39. Ferriani, R.A. et al. (1993) Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum. Reprod. 8, 11-16
40. Pepper, M.S. et al. (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189, 824-831
41. Fujimoto, J. et al. (1996) Expressions of the fibroblast growth factor family (FGF-1, -2 and -4) mRNA in endometrial cancers. Tumour Biol. 17, 226-233
42. Schneeberger, S.A. et al. (1997) Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes. Am. J. Ophthalmol. 124, 447-454
43. Pepper, M.S. et al. (1992) Potent synergism between vascular endothelial cell growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189, 824-831
44. Pepper, M.S. and Mandriota, S.J. (1998) Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells. Exp. Cell Res. 241, 414-425
45. Iruela-Arispe, M.L. et al. (1996) Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J. Clin. Invest. 97, 403-412
46. Sheibani, N. et al. (1997) Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis. Mol. Biol. Cell 8, 1329-1341
47. Guo, N.H. et al. (1997) Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res. 57, 1735-1742
48. O'Reilly M.S. et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285
49. Mandriota, S.J. et al. (1996) Transforming growth factor betal down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J. Biol. Chem. 271, 11500-11505
50. Iruela-Arispe, M.L. and Dvorak, H.F. (1997) Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb. Haemost. 78, 672-677
51. Taraboletti, G. et al. (1997) The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. Cell Growth Differ. 8, 471-479
52. Dawson, D.W. et al. (1997) CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138, 707-717
53. Nor, J.E. et al. (2000) Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J. Vasc. Res. 37, 209-218
54. Salamonsen, L.A. et al. (1997) Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J. Clin. Endocrinol. Metab. 82, 1409-1415
55. Freitas, S. et al. (1999) Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol. Reprod. 61, 1070-1082
56. Mach, F. et al. (1999) T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am. J. Pathol. 154, 229-238
57. Lau, T.M. et al. (1999) The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. Mol. Hum. Reprod. 5, 57-63
58. Macpherson, A.M. et al. (1999) The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium. Hum. Reprod. 14, 3080-3087
59. Kooy J. et al. (1996) Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation. Hum. Reprod. 11, 1067-1072
60. Nisolle, M. et al. (1993) Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil. Steril. 59, 681-684
61. Oosterlynck, D.J. et al. (1993) Angiogenicactivity of peritoneal fluid from women with endometriosis. Fertil. Steril. 59, 778-782
62. McLaren, J. et al. (1996) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 98, 482-489